NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/05/25 | 8-K | Current report filing |
|
   |
20 |
| 11/29/24 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
7 | |
| 11/12/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
224 |
| 11/12/24 | 8-K | Current report filing |
|
|
6 |
| 11/04/24 | 8-K | Current report filing |
|
|
5 |
| 09/09/24 | UPLOAD | SEC-generated letter |
|
1 | |
| 08/22/24 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 08/21/24 | UPLOAD | SEC-generated letter |
|
2 | |
| 08/13/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 08/12/24 | 8-K | Current report filing |
|
|
6 |